Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 ...

In the ever-evolving healthcare media landscape, Digital PR bridges the traditional benefits of reach, share of voice, and ...

The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel ...

The US Food and Drug Administration (FDA) has approved Bavarian Nordic’s chikungunya vaccine Vimkunya for use in individuals ...

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...